Prime Therapeutics faces US price-fixing claims from pharmacies
( July 6, 2026, 20:08 GMT | Official Statement) -- MLex Summary: Trust LLC and nearly 5,000 pharmacies filed a US complaint accusing Prime Therapeutics of entering into a price-fixing agreement with Express Scripts on pharmaceutical reimbursement rates and related fees. “This blatant price-fixing agreement has eliminated the normal market forces and has allowed Prime to enjoy excess revenues at the expense of pharmacies. Co-conspirator Express Scripts demanded and receives a share of those revenues. Together, Prime and Express Scripts unlawfully extract supracompetitive revenue via the price-fixing Agreement,” they said.See attached file. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.